Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Panbela Therapeutics (PBLA) has provided an update.
The board of directors of a company has decided to delist their common stock from the Nasdaq Stock Market and transition to the OTCQB market. Despite failing to meet Nasdaq’s minimum stockholders’ equity requirement, resulting in suspension of trading on Nasdaq, the stock became eligible for quotation on the OTCQB under the symbol “PBLA”. The move to file a Form 25 for delisting from Nasdaq will not affect the stock’s eligibility on the OTCQB. A press release was issued announcing these changes, underscoring the company’s ongoing adaptation to market regulations.
Find detailed analytics on PBLA stock on TipRanks’ Stock Analysis page.